-
1 Comment
Wanbangde Pharmaceutical Holding Group Co., Ltd is currently in a long term downtrend where the price is trading 6.9% below its 200 day moving average.
From a valuation standpoint, the stock is 95.0% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.
Wanbangde Pharmaceutical Holding Group Co., Ltd's total revenue rose by 10.4% to $5B since the same quarter in the previous year.
Its net income has dropped by 99.1% to $207K since the same quarter in the previous year.
Finally, its free cash flow grew by 66.5% to $-172M since the same quarter in the previous year.
Based on the above factors, Wanbangde Pharmaceutical Holding Group Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001P94 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 4B |
|---|---|
| PE Ratio | 82.57 |
| Target Price | None |
| Dividend Yield | 1.4% |
| Beta | 0.63 |
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale segments. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells medical devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and protective equipment. In addition, it provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou City, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002082.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
